ArticlePatterns (New York, N.Y.)2026
Detecting clinically relevant topological structures in multiplexed spatial proteomics using TopKAT.
Article in Patterns (New York, N.Y.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Update of
Authors and funding
7 authors.
Funding
Abstract
Multiplexed spatial proteomics profiling platforms expose the intricate geometric structure of cells in the tumor microenvironment (TME). The spatial arrangement of cells has been shown to have important clinical implications, correlating with disease prognosis and treatment response. These datasets require new statistical methods to test whether cell-level images are associated with patient-level outcomes. We propose the topological kernel association test (TopKAT), which combines persistent homology with kernel testing to determine whether geometric structures created by cells predict continuous, binary, or survival outcomes. TopKAT quantifies the topological structure of cells in each image using persistence diagrams and compares the similarities between persistence diagrams on the basis of the number and lifespan of the detected homologies among cells. We show that TopKAT can be more powerful than existing approaches, particularly when cells arise along the boundary of a ring and demonstrate its utility in breast cancer and colorectal cancer applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.